These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 24298915

  • 1. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa.
    Leshem E, Meltzer E, Stienlauf S, Kopel E, Schwartz E.
    J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T, Bar-Meir M, Eisenberg N, Schwartz E.
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [Abstract] [Full Text] [Related]

  • 3. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers.
    DePetrillo JC, Singer C, Bergagnini IA, Kolakowski P, Edwards B, Smith MA.
    J Travel Med; 2010 Jun; 17(4):217-20. PubMed ID: 20636593
    [Abstract] [Full Text] [Related]

  • 4. Abbreviated atovaquone-proguanil prophylaxis regimens in travellers after leaving malaria-endemic areas: A systematic review.
    Savelkoel J, Binnendijk KH, Spijker R, van Vugt M, Tan K, Hänscheid T, Schlagenhauf P, Grobusch MP.
    Travel Med Infect Dis; 2018 Jun; 21():3-20. PubMed ID: 29242073
    [Abstract] [Full Text] [Related]

  • 5. Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options.
    Meltzer E, Rahav G, Schwartz E.
    Clin Infect Dis; 2018 May 17; 66(11):1751-1755. PubMed ID: 29228132
    [Abstract] [Full Text] [Related]

  • 6. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
    Lau CL, Ramsey L, Mills LC, Furuya-Kanamori L, Mills DJ.
    Clin Infect Dis; 2019 Jun 18; 69(1):137-143. PubMed ID: 30281083
    [Abstract] [Full Text] [Related]

  • 7. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
    Lell B, Luckner D, Ndjavé M, Scott T, Kremsner PG.
    Lancet; 1998 Mar 07; 351(9104):709-13. PubMed ID: 9504515
    [Abstract] [Full Text] [Related]

  • 8. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team.
    Clin Infect Dis; 2001 Oct 01; 33(7):1015-21. PubMed ID: 11528574
    [Abstract] [Full Text] [Related]

  • 9. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA, Miller RS, Miller L, Salas CJ, Tosh D, Macareo L, Smith BL, Fracisco S, Clemens EG, Murphy J, Sousa JC, Dumler JS, Magill AJ.
    Clin Infect Dis; 2012 Jan 15; 54(2):232-9. PubMed ID: 22052893
    [Abstract] [Full Text] [Related]

  • 10. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
    van Genderen PJ, Koene HR, Spong K, Overbosch D.
    J Travel Med; 2007 Jan 15; 14(2):92-5. PubMed ID: 17367478
    [Abstract] [Full Text] [Related]

  • 11. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Camus D, Djossou F, Schilthuis HJ, Høgh B, Dutoit E, Malvy D, Roskell NS, Hedgley C, De Boever EH, Miller GB, International Malarone Study Team.
    Clin Infect Dis; 2004 Jun 15; 38(12):1716-23. PubMed ID: 15227617
    [Abstract] [Full Text] [Related]

  • 12. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
    Overbosch D.
    J Travel Med; 2003 May 15; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
    Kofoed K, Petersen E.
    J Travel Med; 2003 May 15; 10(3):150-4. PubMed ID: 12757688
    [Abstract] [Full Text] [Related]

  • 14. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M, Gutteridge W, Zeman A, Dickins M, Woolley JL.
    J Travel Med; 1999 May 15; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [Abstract] [Full Text] [Related]

  • 15. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD, Kremsner PG, Sukwa TY, van der Berg JD, Shapiro TA, Scott TR, Chulay JD, Malarone Clinical Trials Study Group.
    J Travel Med; 1999 May 15; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [Abstract] [Full Text] [Related]

  • 16. Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention.
    Lopez-Velez R, Bayas JM.
    J Travel Med; 2007 May 15; 14(5):297-305. PubMed ID: 17883460
    [Abstract] [Full Text] [Related]

  • 17. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M, Schlagenhauf P, Toovey S, Schnetzler G, Tatt I, Tomianovic D, Jick SS, Meier CR.
    Travel Med Infect Dis; 2014 May 15; 12(6 Pt B):718-25. PubMed ID: 24934849
    [Abstract] [Full Text] [Related]

  • 18. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T, Okuda J, Ide D, Amano K, Takei Y, Yamaguchi Y.
    J Infect Chemother; 2013 Feb 15; 19(1):20-3. PubMed ID: 22740189
    [Abstract] [Full Text] [Related]

  • 19. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A, Lever AM.
    J Infect; 2012 Sep 15; 65(3):269-74. PubMed ID: 22609735
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.